Skip to main content
Springer logoLink to Springer
. 2026 May 4;33(8):7249–7250. doi: 10.1245/s10434-026-19768-x

ASO Author Reflections: Socioeconomic Disparities in Breast Tumors Persist Despite Universal Healthcare

Carl Sars 1,✉, Ebba K Lindqvist 2,3
PMCID: PMC13337621  PMID: 42081022

Past

Sarcomas of the breast are rare, and heterogeneous tumors encompassing phyllodes tumors, angiosarcomas, and soft-tissue sarcomas collectively represent less than 1% of all breast malignancies. Surgery remains the cornerstone of treatment, yet factors influencing long-term survival remain poorly understood. Socioeconomic status (SES) is a well-established determinant of cancer outcomes in common malignancies such as breast carcinoma,1 but its role in rare breast tumors had not been studied using individual-level data. Existing studies relied on neighborhood-level socioeconomic indices2 or insurance status as proxies,3 limiting their interpretability and generalizability. A particular knowledge gap existed regarding whether SES-related disparities persist within universal healthcare systems, where formal access to treatment is equal for all residents. In the present study, we sought to investigate the association of SES, defined as highest level of attained education and household disposable income, and overall survival among women with sarcomas of the breast in Sweden.4

Present

In this nationwide, population-based cohort study of 473 women diagnosed with sarcomas of the breast in Sweden between 1993 and 2018, we found that lower household income, but not educational attainment, was associated with worse overall survival, even after adjustment for age and comorbidity.4 Women in the lowest income quintile faced more than twice the mortality risk compared with those in the highest quintile. This association was most pronounced among patients with borderline phyllodes tumors. Our findings demonstrate that survival disparities persist even within a system designed to provide equal access to care, suggesting that low income reflects dimensions of disadvantage that extend beyond formal access to care, and that targeted interventions beyond healthcare provision may be needed to address these disparities.

Future

Future studies should continue to examine the association between tumors and long-term outcomes. In the setting of sarcomas and phyllodes tumors of the breast, attention should be directed at exploring disease-specific survival as a complementary endpoint, requiring clinical case-by-case review to minimize misclassification in registry-based cause-of-death data. Distinguishing primary from secondary angiosarcomas, the latter arising after radiation therapy, would further refine prognostic analyses within this heterogeneous group. Larger international collaborations are needed to achieve sufficient statistical power for subgroup analyses across individual tumor categories. Most importantly, the mechanisms underlying income-related disparities—whether driven by differences in health literacy, social support, treatment adherence, or clinician implicit bias—warrant targeted investigation to inform policy interventions that can meaningfully reduce inequities in survival for patients with these rare tumors.

Funding

Open access funding provided by Karolinska Institute. This work was supported by the Karolinska Institutet Research Grant and a private donation from Majje and Erik Näsström.

Disclosure

None reported.

Footnotes

This article refers to: Sars C, Chen EY-T, Johansson ALV, et al. Socioeconomic status and survival in sarcomas of the breast: nationwide cohort study. Ann Surg Oncol. 2026. 10.1245/s10434-026-19688-w.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17(1):5–19. [DOI] [PubMed] [Google Scholar]
  • 2.Obeng-Gyasi S, Bhattacharyya O, Li Y, et al. The implications of neighborhood socioeconomic status on surgical management and mortality in malignant phyllodes patients in the SEER program. Surgery. 2020;168(6):1122–7. [DOI] [PubMed] [Google Scholar]
  • 3.Koenig JL, Tsai CJ, Sborov K, et al. Impact of insurance coverage on outcomes in primary breast sarcoma. Sarcoma. 2018;2018:4626174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sars C, Chen EY-T, Johansson ALV, et al. Socioeconomic status and survival in sarcomas of the breast: nationwide cohort study. Ann Surg Oncol. 2026. 10.1245/s10434-026-19688-w. [DOI] [PMC free article] [PubMed]

Articles from Annals of Surgical Oncology are provided here courtesy of Springer

RESOURCES